|
|
Volumn 87, Issue 5, 2002, Pages 497-501
|
|
Weekly gemcitabine plus Epirubicin as effective chemotherapy for advanced pancreatic cancer: A multicenter phase II study
a
|
|
Author keywords
Chemotherapy; Clinical benefit; Epirubicin (EPI); Gemcitabine (GEM); Tumour response
|
|
Indexed keywords
EPIRUBICIN;
GEMCITABINE;
ADULT;
ADVANCED CANCER;
AGED;
ALOPECIA;
ANEMIA;
APOPTOSIS;
ARTICLE;
BLOOD TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER LOCALIZATION;
CANCER SURVIVAL;
CARDIOTOXICITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DNA REPAIR;
DNA STRAND BREAKAGE;
DOSE TIME EFFECT RELATION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
HUMAN;
LEUKOPENIA;
LIVER TOXICITY;
MUCOSA INFLAMMATION;
MULTICENTER STUDY;
NAUSEA;
NEPHROTOXICITY;
NEUROTOXICITY;
PANCREAS ADENOCARCINOMA;
PANCREAS CANCER;
PHASE 2 CLINICAL TRIAL;
PHLEBITIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
VOMITING;
ADENOCARCINOMA;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
APOPTOSIS;
DEOXYCYTIDINE;
DNA DAMAGE;
DRUG ADMINISTRATION SCHEDULE;
EPIRUBICIN;
FEMALE;
HEMATOLOGIC DISEASES;
HUMANS;
MALE;
MIDDLE AGED;
PANCREATIC NEOPLASMS;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
|
EID: 18544364216
PISSN: 00070920
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.bjc.6600482 Document Type: Article |
|
Times cited : (24)
|
|
References (24)
|
